Literature DB >> 31702390

miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Amir Savardashtaki1,2, Zahra Shabaninejad3, Ahmad Movahedpour1,4, Roxana Sahebnasagh5, Hamed Mirzaei6, Michael R Hamblin7.   

Abstract

Currently, the incidence of colorectal cancer (CRC) is increasing across the world. The cancer stroma exerts an impact on the spread, invasion and chemoresistance of CRC. The tumor microenvironment involves a complex interaction between cancer cells and stromal cells, for example, cancer-associated fibroblasts (CAFs). CAFs can promote neoplastic angiogenesis and tumor development in CRC. Mounting evidence suggests that many miRNAs are overexpressed (miR-21, miR-329, miR-181a, miR-199a, miR-382 and miR-215) in CRC CAFs, and these miRNAs can influence the spread, invasiveness and chemoresistance in neighboring tumor cells via paracrine signaling. Herein, we summarize the pathogenic roles of miRNAs and CAFs in CRC. Moreover, for first time, we highlight the miRNAs derived from CRC-associated CAFs and their roles in CRC pathogenesis.

Entities:  

Keywords:  cancer-associated fibroblasts; colorectal cancer; exosomes; metastasis; miRNAs; normal fibroblasts; oncogenes; tumor-suppressor genes

Mesh:

Substances:

Year:  2019        PMID: 31702390      PMCID: PMC7132634          DOI: 10.2217/epi-2019-0110

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  155 in total

1.  MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

Authors:  Nerea Bitarte; Eva Bandres; Valentina Boni; Ruth Zarate; Javier Rodriguez; Marisol Gonzalez-Huarriz; Ines Lopez; Jesus Javier Sola; Marta M Alonso; Puri Fortes; Jesus Garcia-Foncillas
Journal:  Stem Cells       Date:  2011-11       Impact factor: 6.277

2.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

3.  MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Authors:  Raffaele Baffa; Matteo Fassan; Stefano Volinia; Brian O'Hara; Chang-Gong Liu; Juan P Palazzo; Marina Gardiman; Massimo Rugge; Leonard G Gomella; Carlo M Croce; Anne Rosenberg
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

Review 4.  Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.

Authors:  Ulrike Peters; Shuo Jiao; Fredrick R Schumacher; Carolyn M Hutter; Aaron K Aragaki; John A Baron; Sonja I Berndt; Stéphane Bézieau; Hermann Brenner; Katja Butterbach; Bette J Caan; Peter T Campbell; Christopher S Carlson; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Stephen J Chanock; Lin S Chen; Gerhard A Coetzee; Simon G Coetzee; David V Conti; Keith R Curtis; David Duggan; Todd Edwards; Charles S Fuchs; Steven Gallinger; Edward L Giovannucci; Stephanie M Gogarten; Stephen B Gruber; Robert W Haile; Tabitha A Harrison; Richard B Hayes; Brian E Henderson; Michael Hoffmeister; John L Hopper; Thomas J Hudson; David J Hunter; Rebecca D Jackson; Sun Ha Jee; Mark A Jenkins; Wei-Hua Jia; Laurence N Kolonel; Charles Kooperberg; Sébastien Küry; Andrea Z Lacroix; Cathy C Laurie; Cecelia A Laurie; Loic Le Marchand; Mathieu Lemire; David Levine; Noralane M Lindor; Yan Liu; Jing Ma; Karen W Makar; Keitaro Matsuo; Polly A Newcomb; John D Potter; Ross L Prentice; Conghui Qu; Thomas Rohan; Stephanie A Rosse; Robert E Schoen; Daniela Seminara; Martha Shrubsole; Xiao-Ou Shu; Martha L Slattery; Darin Taverna; Stephen N Thibodeau; Cornelia M Ulrich; Emily White; Yongbing Xiang; Brent W Zanke; Yi-Xin Zeng; Ben Zhang; Wei Zheng; Li Hsu
Journal:  Gastroenterology       Date:  2012-12-22       Impact factor: 22.682

5.  Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

Authors:  Chung Wah Wu; Siew Chien Ng; Yujuan Dong; Linwei Tian; Simon Siu Man Ng; Wing Wa Leung; Wai Tak Law; Tung On Yau; Francis Ka Leung Chan; Joseph Jao Yiu Sung; Jun Yu
Journal:  Clin Cancer Res       Date:  2014-04-01       Impact factor: 12.531

6.  Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells.

Authors:  Haruo Nakano; Tatsuya Miyazawa; Keita Kinoshita; Yoji Yamada; Tetsuo Yoshida
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

7.  Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.

Authors:  Valentina Doldi; Maurizio Callari; Elisa Giannoni; Francesca D'Aiuto; Massimo Maffezzini; Riccardo Valdagni; Paola Chiarugi; Paolo Gandellini; Nadia Zaffaroni
Journal:  Oncotarget       Date:  2015-10-13

8.  Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3.

Authors:  Dong Han; Xu Gao; Meng Wang; Yu Qiao; Ya Xu; Jing Yang; Nazhen Dong; Jun He; Qian Sun; Guixiang Lv; Changqing Xu; Ji Tao; Ning Ma
Journal:  Oncotarget       Date:  2016-04-19

9.  MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor.

Authors:  Praneeth R Kuninty; Linda Bojmar; Vegard Tjomsland; Marie Larsson; Gert Storm; Arne Östman; Per Sandström; Jai Prakash
Journal:  Oncotarget       Date:  2016-03-29

10.  MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation.

Authors:  Qiong Li; Daoxiang Zhang; Yongbin Wang; Pan Sun; Xiaodan Hou; James Larner; Wujun Xiong; Jun Mi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  24 in total

1.  Pregnancy-associated changes in cervical noncoding RNA.

Authors:  Kristin D Gerson; Miriam J Haviland; Dayna Neo; Jonathan L Hecht; Andrea A Baccarelli; Kasey Jm Brennan; Alexandra E Dereix; Steven J Ralston; Michele R Hacker; Heather H Burris
Journal:  Epigenomics       Date:  2020-08-18       Impact factor: 4.778

2.  Network-based analysis implies critical roles of microRNAs in the long-term cellular responses to gold nanoparticles.

Authors:  Priscila Falagan-Lotsch; Catherine J Murphy
Journal:  Nanoscale       Date:  2020-09-29       Impact factor: 7.790

3.  Dysregulated circRNA_100876 contributes to proliferation and metastasis of colorectal cancer by targeting microRNA-516b (miR-516b).

Authors:  Jianrong Zhang; Huaiming Wang; Ketong Wu; Fajie Zhan; Huan Zeng
Journal:  Cancer Biol Ther       Date:  2020-06-21       Impact factor: 4.742

4.  MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway.

Authors:  Wei Wang; Jun Zhang; YunXiu Fan; Li Zhang
Journal:  Cell Cycle       Date:  2022-04-13       Impact factor: 5.173

5.  Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer.

Authors:  Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Xiaorong Zhu; Dilip Deb; Stephen C Meredith; Fatma Ayaloglu-Butun; Michelle Fletcher; Arantxa Sanchez; Joel Pekow; Zifeng Deng; Nader Amini; Vani J Konda; Vijaya L Rao; Atsushi Sakuraba; Akushika Kwesi; Sonia S Kupfer; Alessandro Fichera; Loren Joseph; John Hart; Fang He; Tong-Chuan He; Diana West-Szymanski; Yan Chun Li; Marc Bissonnette
Journal:  Epigenetics       Date:  2020-12-28       Impact factor: 4.528

Review 6.  Roles of exosomes in diagnosis and treatment of colorectal cancer.

Authors:  Yvette Umwali; Cong-Bo Yue; Abakundana Nsenga Ariston Gabriel; Yi Zhang; Xin Zhang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

Review 7.  The role of melatonin in colorectal cancer treatment: a comprehensive review.

Authors:  Mindaugas Kvietkauskas; Viktorija Zitkute; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Ther Adv Med Oncol       Date:  2020-07-17       Impact factor: 8.168

8.  The fiber metabolite butyrate reduces gp130 by targeting TRAF5 in colorectal cancer cells.

Authors:  Yin Yuan; Bo Li; Yanbin Kuang; Shuo Ni; Aoxiang Zhuge; Jing Yang; Longxian Lv; Silan Gu; Ren Yan; Yating Li; Kaicen Wang; Liya Yang; Xueling Zhu; Jingjing Wu; Xiaoyuan Bian; Lanjuan Li
Journal:  Cancer Cell Int       Date:  2020-06-03       Impact factor: 5.722

Review 9.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

10.  Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers.

Authors:  Yuedi Ding; Jun Fan; Lili Deng; Biao Huang; Bin Zhou
Journal:  Cancer Cell Int       Date:  2020-06-15       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.